Ling Ye

3.2k total citations · 1 hit paper
76 papers, 2.6k citations indexed

About

Ling Ye is a scholar working on Pharmacology, Molecular Biology and Pharmacology. According to data from OpenAlex, Ling Ye has authored 76 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 18 papers in Molecular Biology and 12 papers in Pharmacology. Recurrent topics in Ling Ye's work include Pharmacogenetics and Drug Metabolism (15 papers), Berberine and alkaloids research (7 papers) and Plant-based Medicinal Research (7 papers). Ling Ye is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Berberine and alkaloids research (7 papers) and Plant-based Medicinal Research (7 papers). Ling Ye collaborates with scholars based in China, United States and Singapore. Ling Ye's co-authors include Lan Tang, Chinglai Yang, Zheng Cai, Richard W. Compans, Jie Zhao, Mark R. Prausnitz, Zhongqiu Liu, Runzhi Chen, Yingying Fang and Hao Zhou and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Ling Ye

71 papers receiving 2.5k citations

Hit Papers

Transplantation of fecal microbiota rich in short chain f... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Ye China 25 1.0k 377 347 333 274 76 2.6k
V. Ravichandiran India 29 1.5k 1.5× 267 0.7× 389 1.1× 521 1.6× 120 0.4× 263 4.3k
V.G.M. Naidu India 45 2.3k 2.3× 440 1.2× 295 0.9× 450 1.4× 158 0.6× 146 5.8k
Fahad A. Al‐Abbasi Saudi Arabia 33 1.6k 1.6× 455 1.2× 266 0.8× 198 0.6× 130 0.5× 252 4.3k
Xiaoyu Xu China 32 1.6k 1.6× 243 0.6× 251 0.7× 126 0.4× 380 1.4× 224 4.1k
Sami I. Alzarea Saudi Arabia 35 1.7k 1.7× 186 0.5× 222 0.6× 221 0.7× 222 0.8× 199 4.1k
Daxiong Xiang China 36 1.8k 1.8× 287 0.8× 353 1.0× 184 0.6× 120 0.4× 112 3.6k
Chi‐Feng Hung Taiwan 41 1.3k 1.3× 319 0.8× 356 1.0× 422 1.3× 69 0.3× 132 4.4k
Nabil A. Alhakamy Saudi Arabia 34 1.5k 1.5× 163 0.4× 255 0.7× 1.1k 3.2× 82 0.3× 214 4.5k
Obaid Afzal Saudi Arabia 37 1.7k 1.7× 161 0.4× 201 0.6× 423 1.3× 79 0.3× 187 4.4k
Chaomei Fu China 42 1.8k 1.8× 915 2.4× 330 1.0× 254 0.8× 106 0.4× 129 4.4k

Countries citing papers authored by Ling Ye

Since Specialization
Citations

This map shows the geographic impact of Ling Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Ye more than expected).

Fields of papers citing papers by Ling Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Ye. The network helps show where Ling Ye may publish in the future.

Co-authorship network of co-authors of Ling Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Ye. A scholar is included among the top collaborators of Ling Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Ye. Ling Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jiankui, Hui Qiu, Xin Huang, et al.. (2025). Association between statin administration and outcome in patients with sepsis: A retrospective study. Open Medicine. 20(1). 20241112–20241112.
2.
Zhu, Zhengxi, Yao Kang, Qi Liu, et al.. (2024). Continuous preparation of hydro-alcoholic gel with antimicrobial complex nanoparticles via cascaded reactive confined impinging jets micromixing. Chemical Engineering Science. 304. 120972–120972. 2 indexed citations
3.
Hu, Wanyu, Xiaojie Zhao, Cong Xie, et al.. (2024). Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide. Gut Microbes. 16(1). 2387402–2387402. 4 indexed citations
4.
Huang, Xin, Ling Ye, He Li, et al.. (2023). Pharmacogenomics and adverse effects of anti‐infective drugs in children. Clinical and Experimental Pharmacology and Physiology. 51(1). 3–9.
5.
Ye, Ling, Longjian Huang, Wei Tan, et al.. (2022). Clinically Significant Cytochrome P450‐Mediated Drug‐Drug Interactions in Children Admitted to Intensive Care Units. International Journal of Clinical Practice. 2022(1). 2786914–2786914. 3 indexed citations
6.
Wang, Xiaodong, et al.. (2020). MiR-24 alleviates cardiomyocyte apoptosis after myocardial infarction via targeting BIM. SHILAP Revista de lepidopterología. 14 indexed citations
7.
Teng, Chao, Chenshi Lin, Xuyang Xing, et al.. (2020). Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease. Acta Pharmaceutica Sinica B. 10(8). 1521–1533. 47 indexed citations
8.
Ye, Ling, Jiaxing Zhang, Wei Xiao, & Shuwen Liu. (2020). Efficacy and mechanism of actions of natural antimicrobial drugs. Pharmacology & Therapeutics. 216. 107671–107671. 35 indexed citations
9.
Wang, Mengyao, Jie Huang, Yanan Liu, et al.. (2019). Study on bioequivalence of gefitinib tablets in healthy Chinese subjects. Zhongguo linchuang yaolixue yu zhiliaoxue. 24(11). 1275.
10.
Ye, Ling, Rongrong Wang, Yong Li, et al.. (2018). Changes in Microflora and Organic Acid Contents during the Fermentation of Chopped Pepper. Food Science. 39(6). 116. 3 indexed citations
11.
Ye, Ling, Rui Hu, Liwei Liu, et al.. (2018). Comparing Semiconductor Nanocrystal Toxicity in Pregnant Mice and Non-Human Primates. Nanotheranostics. 3(1). 54–65. 15 indexed citations
12.
Ye, Ling, Mingxing Miao, Suning Li, & Kun Hao. (2017). Nanosuspensions of a new compound, ER-β005, for enhanced oral bioavailability and improved analgesic efficacy. International Journal of Pharmaceutics. 531(1). 246–256. 9 indexed citations
13.
Ye, Ling & Chinglai Yang. (2014). Development of vaccines for prevention of Ebola virus infection. Microbes and Infection. 17(2). 98–108. 21 indexed citations
14.
Pan, Qingjun, Yaning Li, Ling Ye, et al.. (2014). Geographical distribution, a risk factor for the incidence of lupus nephritis in China. BMC Nephrology. 15(1). 67–67. 17 indexed citations
15.
Ye, Ling, Linlin Lu, Ye Li, et al.. (2013). Potential role of ATP-binding cassette transporters in the intestinal transport of rhein. Food and Chemical Toxicology. 58. 301–305. 16 indexed citations
16.
Tang, Lan, et al.. (2011). Involvement of CYP3A4/5 and CYP2D6 in the metabolism of aconitine using human liver microsomes and recombinant CYP450 enzymes. Toxicology Letters. 202(1). 47–54. 75 indexed citations
17.
Ye, Ling, et al.. (2010). Absorption characteristics of andrographolide in rat intestine in situ. Zhongcaoyao. 41(2). 219–222. 1 indexed citations
18.
Zhu, Qiyun, Vladimir Zarnitsyn, Ling Ye, et al.. (2009). Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge. Proceedings of the National Academy of Sciences. 106(19). 7968–7973. 170 indexed citations
19.
Wei, Jia, Zhengyun Zou, Xiaoping Qian, et al.. (2008). ERCC1 mRNA levels and survival of advanced gastric cancer patients treated with a modified FOLFOX regimen. British Journal of Cancer. 98(8). 1398–1402. 58 indexed citations
20.
Bu, Zhigao, Ling Ye, Richard W. Compans, & Chinglai Yang. (2003). Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins. Virology. 309(2). 272–281. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026